Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
16
APLT Quote, Financials, Valuation and Earnings
Last price:
$0.12
Seasonality move
:
28.77%
Day range:
$0.12 - $0.13
52-week range:
$0.10 - $1.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.56x
P/B ratio:
1.80x
Volume:
3.9M
Avg. volume:
21.6M
1-year change:
-85.77%
Market cap:
$16.8M
Revenue:
$455K
EPS (TTM):
-$0.10
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
$250K | -$0.14 | 104.92% | -70.54% | $0.25 |
|
AMIX
Autonomix Medical, Inc.
|
-- | -- | -- | -- | $6.60 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.38 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
$0.12 | $0.25 | $16.8M | -- | $0.00 | 0% | 16.56x |
|
AMIX
Autonomix Medical, Inc.
|
$0.60 | $6.60 | $4.1M | -- | $0.00 | 0% | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$5.43 | $0.85 | $684.2M | 9.12x | $0.80 | 0% | 10.55x |
|
OGEN
Oragenics, Inc.
|
$0.83 | $2.00 | $685.6K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.19 | $7.00 | $6.5M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
128.93% | 3.416 | 2.86% | 0.36x |
|
AMIX
Autonomix Medical, Inc.
|
-- | 0.300 | -- | 5.03x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
OGEN
Oragenics, Inc.
|
3.86% | -0.075 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -3.365 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
$889K | -$16.8M | -70.3% | -77.88% | -1675.8% | -$18.4M |
|
AMIX
Autonomix Medical, Inc.
|
-$2K | -$7.5M | -228.46% | -243.23% | -- | -$3.8M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
Applied Therapeutics, Inc. vs. Competitors
-
Which has Higher Returns APLT or AMIX?
Autonomix Medical, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Autonomix Medical, Inc.'s return on equity of -243.23%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M AMIXAutonomix Medical, Inc.-- -$1.38 $6.4M -
What do Analysts Say About APLT or AMIX?
Applied Therapeutics, Inc. has a consensus price target of $0.25, signalling upside risk potential of 99.68%. On the other hand Autonomix Medical, Inc. has an analysts' consensus of $6.60 which suggests that it could grow by 923.73%. Given that Autonomix Medical, Inc. has higher upside potential than Applied Therapeutics, Inc., analysts believe Autonomix Medical, Inc. is more attractive than Applied Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.0 4 0 AMIXAutonomix Medical, Inc.1 0 0 -
Is APLT or AMIX More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Autonomix Medical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock APLT or AMIX?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Autonomix Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Autonomix Medical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or AMIX?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Autonomix Medical, Inc. quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is lower than Autonomix Medical, Inc.'s net income of -$7.5M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Autonomix Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 16.56x versus -- for Autonomix Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.16.56x -- $1M -$19M AMIXAutonomix Medical, Inc.-- -- -- -$7.5M
-
Which has Higher Returns APLT or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of -255.85%. Applied Therapeutics, Inc.'s return on equity of -77.88% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About APLT or NBY?
Applied Therapeutics, Inc. has a consensus price target of $0.25, signalling upside risk potential of 99.68%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -84.35%. Given that Applied Therapeutics, Inc. has higher upside potential than NovaBay Pharmaceuticals, Inc., analysts believe Applied Therapeutics, Inc. is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.0 4 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is APLT or NBY More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock APLT or NBY?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or NBY?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Applied Therapeutics, Inc.'s net income of -$19M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 9.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 16.56x versus 10.55x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.16.56x -- $1M -$19M NBYNovaBay Pharmaceuticals, Inc.10.55x 9.12x $521K -$1.3M
-
Which has Higher Returns APLT or OGEN?
Oragenics, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About APLT or OGEN?
Applied Therapeutics, Inc. has a consensus price target of $0.25, signalling upside risk potential of 99.68%. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 140.07%. Given that Oragenics, Inc. has higher upside potential than Applied Therapeutics, Inc., analysts believe Oragenics, Inc. is more attractive than Applied Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.0 4 0 OGENOragenics, Inc.1 0 0 -
Is APLT or OGEN More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.781%.
-
Which is a Better Dividend Stock APLT or OGEN?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or OGEN?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Oragenics, Inc. quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is lower than Oragenics, Inc.'s net income of -$3.1M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 16.56x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.16.56x -- $1M -$19M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns APLT or PTN?
Palatin Technologies has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M PTNPalatin Technologies-- -- -- -
What do Analysts Say About APLT or PTN?
Applied Therapeutics, Inc. has a consensus price target of $0.25, signalling upside risk potential of 99.68%. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than Applied Therapeutics, Inc., analysts believe Palatin Technologies is more attractive than Applied Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.0 4 0 PTNPalatin Technologies0 0 0 -
Is APLT or PTN More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock APLT or PTN?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or PTN?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Palatin Technologies quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is higher than Palatin Technologies's net income of --. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 16.56x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.16.56x -- $1M -$19M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns APLT or TOVX?
Theriva Biologics, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About APLT or TOVX?
Applied Therapeutics, Inc. has a consensus price target of $0.25, signalling upside risk potential of 99.68%. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3528.82%. Given that Theriva Biologics, Inc. has higher upside potential than Applied Therapeutics, Inc., analysts believe Theriva Biologics, Inc. is more attractive than Applied Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.0 4 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is APLT or TOVX More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.818%.
-
Which is a Better Dividend Stock APLT or TOVX?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or TOVX?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Theriva Biologics, Inc. quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is lower than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 16.56x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.16.56x -- $1M -$19M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
